Main Catalog

Found 95
Sort By
eLearning Days 2020
Member Free
Non-Member

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars

Contact Hours: 1 - This session focuses on new and emerging traditional pharmaceutical brand-name drugs, as well as upcoming generic and biosimilar drug approvals.
Drug Pipeline
eLearning Days 2020
Member Free
Non-Member

Evaluating Digital Therapeutics, Drugs, and Health Technology for Optimizing Clinical and Financial Outcomes

Contact Hours: 1 - Utilization management practices are applied to medications in many therapeutic areas, but present unique challenges with digital therapeutics (DTx) and digital health tools.
Digital Therapeutics
eLearning Days 2020
Member Free
Non-Member

Health Policy Trends Impacting Managed Care Pharmacy: Are You Ready?

Not Accredited for CPE: Congress, the White House, and presidential candidates are proposing major health policy changes in an election year where health care is a top issue on voters’ minds.
Health Policy
eLearning Days 2020
Member Free
Non-Member

Developing Professional Strategies to Enhance Digital Engagement

Not Accredited for CPE: 2020 will no doubt be the year of digital engagement. On this webinar, Digital Marketing Strategist Eddie Bradley will share tips and insights on how subject matter experts and industry leading brands are leveraging content to grow and further engage with their audience.
Digital Engagement
eLearning Days 2020
Member Free
Non-Member

Cannabis Use in Health Care: What Payers Need to Know

Contact Hours: 1 - Despite a lack of regulatory and legal clarity, significant numbers of patients in Medicare, Medicaid, CHIP, and commercial plans currently use medical cannabis.
Cannabis
eLearning Days 2020
Member Free
Non-Member

Getting Up to Speed on Prescription Drug Pricing Reform Efforts

Contact Hours: 1 - Prescription drug pricing reform is a high-profile issue heading into the 2020 elections. President Trump, members of Congress, and the Democratic presidential candidates.
Drug Pricing
eLearning Days 2020
Member Free
Non-Member

Oncology: Investigating Trends and Elucidating Value

Contact Hours: 1 - Cancer is one of the world’s most pressing health care challenges, with more than 14 million people receiving a cancer diagnosis each year.
Oncology
eLearning Days 2020
Member Free
Non-Member

Placing Potential Cures Within Reach: Real-World Experience and Evolving Management

Contact Hours: 1 - A prominent health care payer and pharmacy benefit manager (PBM) will share their real-world experiences and learnings in managing innovative and expensive gene therapies.
Real World Evidence
Specialty Connect
Member Free
Non-Member Free

Innovations in Managed Care for Oncology Specialty Pharmacy

Contact Hours: 1 - Benefit designs and management tools promoting high-quality care while simultaneously addressing total cost of care.
Oncology
Nexus 2020 Virtual
Member
Non-Member

Managing Different Perspectives: Panel Discussion on Integrating Medical and Pharmacy Benefits

Contact Hours: 1 - With several new treatments crossing the traditional dividing lines between medical and pharmacy benefits, there are many questions on how to best manage the coverage for these medications.
Pharmacy Benefits
Nexus 2019
Member Free
Non-Member Free

Expanding the Managed Care Professional’s Digital Therapeutics IQ

Contact Hours: 1.5. Digital therapeutics are expanding the boundaries of the types of therapies that health care decision-makers must be adept at evaluating.
Digital Therapeutics
eLearning Days 2020
Member Free
Non-Member

Digital Therapeutics: Understanding the Emerging Product Class

Contact Hours: 1 - Digital therapeutics (DTx) are emerging as a novel treatment modality for a wide range of health conditions, either as stand-alone products or for use in conjunction with other treatments.
Digital Therapeutics
Specialty Connect
Member Free
Non-Member Free

Evolving Oncology Treatment Options— Recent Approvals and a Look to the Future

Contact Hours: 1 - Over 1,100 biopharmaceutical products are currently in the oncology pipeline andnumerous new treatments approved by the FDA each year.
Drug Pipeline Oncology
Specialty Connect
Member Free
Non-Member Free

Legal and Regulatory Considerations Impacting Oncology Specialty Pharmacy

Contact Hours: 1 - Laws and regulations at the state and federal level that impact oncology care.
Legislation Oncology
Specialty Connect
Member Free
Non-Member Free

Perspectives on Providing Value in Oncology: A Panel Discussion

Contact Hours: 1 - Perceptions of value in oncology care vary among stakeholders.
Oncology
Nexus 2019
Member Free
Non-Member

The Times They Are a-Changin – A Look at Congressional Efforts to Reform the Medicare and Medicaid Prescription Drug Programs

Contact Hours: 1.5. For more than a decade, millions of American seniors have been able to access prescription drugs through market-driven programs.
Medicare and Medicaid Health Care Reform
Nexus 2019
Member Free
Non-Member

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.
Value-Based Contracting Alzheimer's
Nexus 2020 Virtual
Member
Non-Member

Keeping Up with Rare Disease Therapies: Pipeline to Management Solutions Track

Contact Hours: 1 - Over the last several years, payers have increased their focus on the management of rare diseases.
Drug Pipeline Rare Diseases
Nexus 2020 Virtual
Member
Non-Member

Value-Based Payment Models: Opportunities to Integrate Pharmacists from a Variety of Practice Settings

Contact Hours: 1 - Shared savings plans can mitigate health care costs, but how do we establish the relationships required for their success?
Value-Based Contracting
Nexus 2020 Virtual
Member
Non-Member

The Role of Health Disparities and Social Determinants of Health in Promoting Health and Health Equity

Contact Hours: 1 - Health care disparities are often viewed through the lens of race/ethnicity and socioeconomic status.
Health Disparities Social Determinants
Nexus 2020 Virtual
Member
Non-Member

Keeping Up with State Legislators: Legislative Updates and Outlook

Contact Hours: 1 - The COVID-19 pandemic had a significant impact on state legislation and regulation.
Legislation
Nexus 2019
Member Free
Non-Member

Biosimilars in the United States: Barriers, Solutions, Real-World Evidence, and the Experience of One Health System

Contact Hours: 1.5. As of July 2019, the U.S. Food and Drug Administration (FDA) had approved 25 biosimilar or follow-on biologic products.
Real World Evidence Biosimilars
Webcasts
Member Free
Non-Member Free

Navigating Changes in Clostridioides difficile Prevention and Treatment

Contact Hours: 1. 5 - Clostridioides difficile (C. diff, previously known as Clostridium difficile) infections are a major health care concern.
C. Diff
Nexus 2020 Virtual
Member
Non-Member

White and Brown Bagging: Emerging Practice, Legislative and Board of Pharmacy Trends

Contact Hours: 1 - The growth of specialty pharmacy has resulted in an increase of white bagging and brown bagging.
Brown Bagging
Webcasts
Member Free
Non-Member

Health Care Trends and the Impact of COVID-19

Not Accredited for CPE: The COVID-19 global pandemic has had a tremendous impact on the health care community. As the pandemic continues, it is vital to remain informed on how it has affected overall health care trends and, specifically, how those trends have impacted managed care pharmacy.
Covid-19
Nexus 2019
Member Free
Non-Member

Increasing Positive Outcomes: The Impact of Social Determinants of Health

Contact Hours: 1.5. There is a growing body of evidence that highlights how social determinants of health—socioeconomic status, education, physical environment, employment, and social support networks—play a large role in determining overall health outcomes.
Social Determinants
Nexus 2019
Member Free
Non-Member

Fast and Furious: What is Driving the Specialty Spend?

Contact Hours: 1.5. In 2018, the United States spent an estimated $517 million on specialty drugs. While specialty medications make up only about 1–2 % of all prescriptions written, they account for nearly 50% of total drug spend.
Specialty Drug Spend
Nexus 2019
Member Free
Non-Member

Specialty Pharmaceuticals in Development - Nexus 2019

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus 2020 Virtual
Member
Non-Member

Impact of Prescription Drug Reference Pricing on Drug Spend and Utilization

Contact Hours: 1 - Prescription drug reference pricing is an emerging pharmacy benefit management tool that aligns plan reimbursement to clinical value.
Drug Pricing
Nexus 2020 Virtual
Member
Non-Member

Overcoming Barriers to Biosimilar Adoption through Coordinated Efforts

Contact Hours: 1 - Biosimilars are considered a fundamental pillar to containing drug spend in today’s health care systems.
Biosimilars
Nexus 2020 Virtual
Member
Non-Member

Population Management: Zooming in on Rare Diseases with ICER Reports

Contact Hours: 1 - An estimated 10% of the population has a rare disease, according to the National Organization of Rare Disorders (NORD), which lists over 1,200 rare diseases.
ICER
Nexus 2020 Virtual
Member
Non-Member

Specialty Pharmaceuticals in Development Nexus 2020

Contact Hours: 1 - Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus 2020 Virtual
Member
Non-Member

The Evolving Role of Managed Care in the Gene Therapy Era: Focus on Hemophilia

Contact Hours: 1 - The first gene therapies for hemophilia A and B are expected to reach the market by 2022, with more projected in the coming years.
Gene Therapy
Nexus 2020 Virtual
Member
Non-Member

The State of Prescription Drug Pricing Reform: Are States Leading the Way for the US?

Contact Hours: 1 - Debates from Washington, D.C. frequently drown out changes happening in state capitals. This is true for drug pricing as well.
Drug Pricing
Nexus 2019
Member Free
Non-Member

The Managed Care Evaluation of Non-Alcoholic Steatohepatitis Treatment Options

Contact Hours: 1.5. Non-alcoholic steatohepatitis (NASH) is a liver disease resulting from metabolic dysfunction that can lead to serious and costly health conditions, such as inflammation, hepatocellular injury, progressive fibrosis, and cirrhosis.
NASH
Nexus 2019
Member Free
Non-Member

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
Nexus 2019
Member Free
Non-Member

Checking In on Health Care Reform Efforts: What Do They Mean for Payers, Manufacturers, and Patients?

Contact Hours: 1.5. While broader drug pricing reform efforts have taken the lion’s share of attention in health policy discourse over the past year, the Trump Administration has continued to move forward with implementing changes to the Affordable Care Act (ACA).
Health Care Reform
Nexus 2019
Member Free
Non-Member

Innovative Value-Based Contracting Approaches with Comprehensive Clinical Strategies

Contact Hours: 1.5. Innovative approaches to developing value-based contracts in the market need to be multi-faceted.
Value-Based Contracting
Nexus 2019
Member Free
Non-Member

Releasing Format Version 4.1: Updates, Perspectives and Application

Contact Hours: 1.5. The Academy of Managed Care Pharmacy developed the AMCP Format for Formulary Submission
Format 4.1
Nexus 2019
Member Free
Non-Member

How Continued Drug Shortages Compromise Patient Care

Contact Hours: 1.5. Providing safe and effective drug therapy has become extremely challenging during extended periods of drug shortages.
Drug Shortages
Certificate Programs
Member
Non-Member

Medical Benefits Training - Provider & Health Plan Version

AMCP’s Medical Benefit Medication Management is an 8-part series built specifically for members of Life Science companies.
Medical Benefits Training
Certificate Programs
Member
Non-Member

Medical Benefits Training - Life Sciences Version

AMCP’s Medical Benefit Medication Management is an 8-part series built specifically for members of Life Science companies.
Medical Benefits Training
Certificate Programs
Member
Non-Member

Value-Based Contracting E-Learning Program

Not accredited for CPE: An interactive self-paced e-Learning training program designed to fit into your busy schedule and deliver the basics with seven 40-minute modules.
Value-Based Contracting
Certificate Programs
Member
Non-Member

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

Not Accredited for CPE: The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy
Certificate Programs
Member
Non-Member

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 - The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.
Fundamentals of Managed Care Pharmacy